Brought to you by 
Human Genome Sciences acquires Principia Pharma for $135mm
12 Sep 2001
Executive Summary
Just a week after filing a shelf registration to raise up to $1bn, Human Genome Sciences acquired private development-stage pharmaceutical company Principia in a stock-for-stock transaction valued at $135mm. HGS issued 1.58mm common shares valued at $82.23 each.
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
- Drug Delivery
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Intra-Biotech Deal
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com